Related Experiment Video
Updated: Apr 23, 2026

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis
Published on: February 6, 2021
Acute-onset postoperative endophthalmitis caused by multidrug-resistant Klebsiella pneumoniae
Shekhar Sanghi1, Avinash Pathengay1, Animesh Jindal1
1Department of Ophthalmology, L V Prasad Eye Institute, GMR Varalakshmi Campus, Visakhapatnam, Andhra Pradesh, India.
Abstract:
The purpose of this paper is to report outcomes of intravitreal imipenem in the treatment of multidrug-resistant Klebsiella-related postoperative endophthalmitis. This observational case series consists of three eyes from three patients seen between 2013 and 2014. Multidrug-resistant Klebsiella pneumoniae is characterized by a rapid, fulminant course and severe intraocular inflammation. Intravitreal imipenem may be used to treat such infection.
Insights
Intravitreal imipenem shows promise for treating severe eye infections caused by multidrug-resistant Klebsiella pneumoniae. This treatment approach may be effective against this aggressive form of postoperative endophthalmitis.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Microbiology
Background:
- Postoperative endophthalmitis can be caused by multidrug-resistant bacteria.
- Klebsiella pneumoniae is a significant pathogen associated with severe intraocular inflammation and rapid disease progression.
Purpose of the Study:
- To report the outcomes of using intravitreal imipenem for treating multidrug-resistant Klebsiella-related postoperative endophthalmitis.
Main Methods:
- Observational case series.
- Treatment involved intravitreal administration of imipenem.
- Data collected from three patients between 2013 and 2014.
Main Results:
- Intravitreal imipenem was administered to three patients with severe endophthalmitis.
- The study observed the outcomes of this treatment approach.
Conclusions:
- Intravitreal imipenem may serve as a viable treatment option for postoperative endophthalmitis caused by multidrug-resistant Klebsiella.
- Further research is warranted to confirm the efficacy and safety of this therapeutic strategy.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis I: Introduction
Microbiome of the Eye
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.

